Kurt Brorson, Ph.D. is a staff scientist in CDER’s Division of Monoclonal Antibodies, Office of Biotech Products. Kurt Brorson received a B.A. in biology from the University of Chicago (Chicago IL) in 1984 and Ph.D. in molecular biology from the California Institute of Technology (Pasadena CA) in 1990. After a 2-year postdoctoral fellowship at the NIH, he joined FDA in 1992 as a staff fellow and was promoted to a staff scientist in 1999. In addition to review, inspection, training and policy activities, he conducts research on viral safety issues associated with biotechnology products. He has won numerous internal awards from FDA, CBER and CDER and is the author of more than 40 scientific journal articles and book chapters. He is a member of PDA, the American Chemical Society, the American Association for the Advancement of Science and the American Society for Microbiology.